Your browser doesn't support javascript.
loading
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.
Visentin, Andrea; Bonaldi, Laura; Rigolin, Gian Matteo; Mauro, Francesca Romana; Martines, Annalisa; Frezzato, Federica; Imbergamo, Silvia; Scomazzon, Edoardo; Pravato, Stefano; Bardi, Maria Antonella; Cavallari, Maurizio; Volta, Eleonora; Cavazzini, Francesco; Nanni, Maurizio; Del Giudice, Ilaria; Facco, Monica; Guarini, Anna; Semenzato, Gianpietro; Foà, Robin; Cuneo, Antonio; Trentin, Livio.
Afiliação
  • Visentin A; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Bonaldi L; Venetian Institute of Molecular Medicine, Padua, Italy.
  • Rigolin GM; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padua, Italy.
  • Mauro FR; Hematology section, Department of Medical Sciences, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.
  • Martines A; Hematology division, Department of Translational and Precision Medicine, "Sapienza" University, Rome, Italy.
  • Frezzato F; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padua, Italy.
  • Imbergamo S; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Scomazzon E; Venetian Institute of Molecular Medicine, Padua, Italy.
  • Pravato S; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Bardi MA; Venetian Institute of Molecular Medicine, Padua, Italy.
  • Cavallari M; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Volta E; Venetian Institute of Molecular Medicine, Padua, Italy.
  • Cavazzini F; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Nanni M; Venetian Institute of Molecular Medicine, Padua, Italy.
  • Del Giudice I; Hematology section, Department of Medical Sciences, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.
  • Facco M; Hematology section, Department of Medical Sciences, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.
  • Guarini A; Hematology section, Department of Medical Sciences, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.
  • Semenzato G; Hematology section, Department of Medical Sciences, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.
  • Foà R; Hematology division, Department of Translational and Precision Medicine, "Sapienza" University, Rome, Italy.
  • Cuneo A; Hematology division, Department of Translational and Precision Medicine, "Sapienza" University, Rome, Italy.
  • Trentin L; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
Br J Cancer ; 121(2): 150-156, 2019 07.
Article em En | MEDLINE | ID: mdl-31209327
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Aberrações Cromossômicas / Cadeias Pesadas de Imunoglobulinas / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Aberrações Cromossômicas / Cadeias Pesadas de Imunoglobulinas / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article